Hansa Biopharma AB (HNSA.ST) Q3 2026 Earnings

16JulConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
-2.59
-1.65
-0.72
0.22

Details

Expected EPS
0.22175440268800004
Actual EPS
N/A
Surprise EPS
-0.22
Surprise Percent
+100%

Description

Hansa Biopharma AB (HNSA.ST) will report earnings of for Q3 2026 on July 16, 2026.

0 Comments

Share your thoughts